Daré Bioscience Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/S Ratio2774.4510.857.04
P/B Ratio-4.51-6.036.343.95-47.78
Price/Tangible Book6.343.95
Price/FCF5.63
Price/OCF5.03
Enterprise Value Ratios
EV/Revenue1769.855.973.06
EV/FCF3.59
Profitability & Returns
Return on Equity (ROE)-9.95%-1.24%-2.06%
Return on Assets (ROA)-0.68%-0.59%-0.39%-0.77%-2.28%
Return on Capital Employed (ROCE)-47.65%-38.34%-2.57%-0.98%249.36%
Leverage & Solvency Ratios
Debt/Equity-0.22-0.280.040.01-0.66
Debt/FCF0.27
Liquidity Ratios
Current Ratio0.850.861.363.440.91
Quick Ratio0.740.561.153.290.67
Efficiency Ratios
Asset Turnover0.000.090.20
Yield & Distribution Ratios
Earnings Yield-0.15%-0.99%-0.44%-0.25%-0.50%
FCF Yield0.18%-1.30%-0.26%-0.19%-0.46%
Buyback Yield-0.17%-0.03%-0.38%-1.03%-0.93%